MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijcha.2022.101030

Медицинская библиотека · International journal of cardiology. Heart & vasculature · 2022

Mid-term results of surgical aortic valve replacement with bioprostheses in hemodialysis patients.

Shibasaki Ikuko, Fukuda Taira, Ogawa Hironaga, Tsuchiya Go, Takei Yusuke, Seki Masahiro, Kato Takashi, Kanazawa Yuta, Saito Shunsuke, Kuwata Toshiyuki, Yamada Yasuyuki, Haruyama Yasuo, Fukuda Hirotsugu

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Limited studies have assessed the factors affecting prognosis in hemodialysis (HD) patients who undergo surgical aortic valve replacement with a bioprostheses (SAVR-BP). This study aimed to evaluate the outcomes of HD patients who had undergone SAVR-BP for aortic stenosis (AS) and identify the risk factors for mortality.

METHODS

This retrospective study included 57 HD patients who had undergone SAVR-BP for AS between July 2009 and December 2020. Multivariate logistic regression was used to predict factors associated with mid-term outcomes and death or survival. Kaplan - Meier curves were also generated for mid-term survival.

RESULTS

The in-hospital mortality rate was 8.8%, and the 5-year mortality rate was 42.1%. The independent predictors of 5-year mortality were preoperative age (hazard ratio [HR], 1.57; 95% confidence interval [CI], 1.175-2.083, p = 0.002), hyperlipidemia (HR, 0.02; 95% CI, 0.002-0.297, p = 0.004), left ventricular diastolic diameter (HR, 1.74; 95% CI, 1.142-2.649, p = 0.010), left ventricular systolic diameter (HR, 0.61; 95% CI, 0.392-0.939, p = 0.025), and Japan SCORE (HR, 1.28; 95% CI, 1.052-1.563, p = 0.014). The postoperative predictors included intensive care unit stay (HR, 1.11; 95% CI, 1.035-1.194, p = 0.004) and albumin level (HR, 0.38; 95% CI, 0.196-0.725, p = 0.003).

CONCLUSIONS

The 5-year prognosis of HD patients undergoing SAVR may be improved by early diagnosis (before the occurrence of LV hypertrophy/enlargement) and nutritional management with oral intake to alleviate postoperative hypoalbuminemia.Registration number of clinical studies: UMIN000047410.

Для цитирования: Shibasaki Ikuko, Fukuda Taira, Ogawa Hironaga, Tsuchiya Go, Takei Yusuke, Seki Masahiro, Kato Takashi, Kanazawa Yuta, Saito Shunsuke, Kuwata Toshiyuki, Yamada Yasuyuki, Haruyama Yasuo, Fukuda Hirotsugu. Mid-term results of surgical aortic valve replacement with bioprostheses in hemodialysis patients.. International journal of cardiology. Heart & vasculature. 2022. DOI: 10.1016/j.ijcha.2022.101030.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.